The hybrid cell B6 line, which synthesizes 
The hybrid cell B6 line, which synthesizes large amounts of hyaluronate as the predominant glycosaminoglycan, was grown in the presence of [3H] [3H] hyaluronate and elongation of nascent chains in vitro commenced from low-molecular-weight chains. Thus nascent hyaluronate chains were degraded extracellularly by hyaluronidase and were therefore synthesized at the inner side of plasma membranes and extruded to the cell surface.
Hyaluronate has recently been shown to be synthesized at the reducing end by alternate transfer of UDP-hyaluronate to the substrates UDP-GlcNAc and UDP-GlcA (Prehm, 1983a,b) . This mechanism differs from the synthesis of glycopeptides and proteoglycans, which are elongated at the non-reducing end on lipid carriers or on protein primers, respectively. Hyaluronate is the only glycosaminoglycan to be produced both by mammalian cells and bacteria. Since bacteria do not possess intracellular organelles, they cannot synthesize hyaluronate in Golgi vesicles and cannot secrete it by fusion of secretory vesicles with plasma membranes. Therefore it seemed likely that hyaluronate is also secreted in mammalian cells by another mechanism. (a) The cell sediment was suspended in 100I4 of hyaluronate solution (10 mg/ml). One-half of this solution was added to sample (c). The rest was twice frozen and thawed, supplemented with substrate A and incubated for 30min at 37°C. After addition of I0 I of 10% (w/v) SDS the suspension was boiled for 3min and filtered on a Sephacryl S-1000 column (0.8cm x 96cm) with phosphate-buffered saline containing 0.1% SDS as eluent at a flow rate of 5.6ml/h. Fractions (0.7 ml) were collected and 0.5 ml aliquots were withdrawn for determination of the radioactivity.
Materials and methods

Materials
(b) The cell pellet was suspended in 1 ml of phosphate-buffered saline containing 5 NF units of bacterial hyaluronidase for 30min at 370C. The cells were washed twice with 15ml of cold phosphate-buffered saline, suspended in 100,4 of Vol. 220 hyaluronate solution (1Omg/ml) and processed further as sample (a).
(c) The cell pellet was treated in the same way as described for sample (b) except that one-half of sample (a) was added after washing with phosphate-buffered saline.
Introduction of[3H]hyaluronate into the cell, hyaluronidase digestion and elongation of hyaluronate in vitro B6 cells (6.3 x 106) grown for 2 days were washed twice with phosphate-buffered saline and incubated for 10min at 37°C with a mixture of 0.3ml of [3H]hyaluronate (4.6 x 105 c.p.m.), 0.5 ml of 1 Msucrose and 0.2ml of 50% (v/v) poly(ethylene glycol) 1000 in Dulbecco's modified Eagles medium. The mixture was centrifuged for 3 min at 10OOg and the cell pellet was incubated with a mixture of 6ml of Dulbecco's modified Eagles medium and 4ml of water and again sedimented for 3min at 1000g. The cell pellet was once again subjected to this incubation sequence and then incubated with 3 NF units of hyaluronidase in 1 ml of phosphate-buffered saline for 30min at 37°C. The cells were sedimented for 3min at O000g, washed twice with 15ml of phosphate-buffered saline, suspended in 100II of unlabelled hyaluronate (1 mg) and 100 sl of substrate A, disrupted by freezing and thawing, and incubated for 30min at 37°C. After addition of IOMl of 10% (w/v) SDS the suspension was boiled for 3min and filtered on Sephacryl S-1000.
Results
Intact B6 cells were mixed with substrate A in phosphate-buffered saline.One-half was incubated directly, the other half was frozen and thawed to disrupt the cells and hyaluronate synthesis was measured as described by Prehm (1980) . The hyaluronate synthase activity in intact cells was 10% of that in disrupted cells. Because UDPGlcNAc and UDP-GIcA are not taken up by cells, hyaluronate synthase must be localized intracellularly.
The following experiments were designed to distinguish between an intracellular or extracellular growth of nascent chains.
B6 cells were labelled with [3H]glucosamine and supplemented with serum, which is known to stimulate hyaluronate synthesis several-fold (Tomida et al., 1975) . After disruption of the cells, hyaluronate synthesis was started by addition of substrate A for 30min and chain length was determined by gel filtration on Sephacryl S-1000. Fig. l(a) shows the elution profile of the 3H-and 14C-labelled material. The radioactivity eluting in fractions 20-60 was hyaluronate, because it was susceptible to bacterial hyaluronidase. The majority of the hyaluronate was eluted in the excluded volume with some tailing into the included volume. The following experiment demonstrated that no residual hyaluronidase was left in the incubation mixture which could account for partially degraded hyaluronate. Untreated and hyaluronidasedigested cells were mixed, incubated with substrate A and the mixture was again chromatographed on Sephacryl S-1000 (Fig. 1c) . The [3H]hyaluronate was eluted undegraded in the excluded volume and the [I4C]hyaluronate again in the included fractions. The radioactivity in fractions 34-55 was hyaluronate, because it was degraded by bacterial hyaluronidase.
To exclude the possibility that hyaluronidase was internalized by cells and digested to nascent chains intracellularly, [3H]hyaluronate of high molecular weight was introduced into the cell by osmotic lysis of pinocytotic vesicles (Okada & Rechsteiner, 1982 (Fig. 2) (Sugahara et al., 1979; Mason et al., 1982; Prehm, 1983a,b) or lipid intermediates (Ishimoto & Strominger, 1967) . It was not inhibited by cycloheximide (Mapleson & Buchwald, 1981) , xylosides (Hopwood & Dorfman, 1977) or tunicamycin (Hart & Lennarz, 1978) . Hyaluronate was synthesized at the reducing end by alternate transfer of the chains to the substrate UDP-GlcNAc and UDP-GlcA. Chains can be initiated by the substrates themselves. Synthesis occured at membranes and was abolished by detergents (Prehm, 1983a,b) .
The hybrid cell B6 derived from mouse mammary carcinoma and a Chinese hamster lung cell line These results are compatible with the notion that hyaluronate is synthesized inside the cell at plasma membranes and extruded to the extracellular matrix.
